완화 케어 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, palliative care market size in 2026 is estimated at USD 165.27 billion, growing from 2025 value of USD 152.85 billion with 2031 projections showing USD 244.01 billion, growing at 8.12% CAGR over 2026-2031.

This report Segments the Industry Into by Provider (Hospitals and Clinics, Nursing Homes, and More), by Care Setting (In-Patient Hospital, and More), by Service Type (Pain & Symptom Management, and More), by Application (Cancer, Cardiovascular Disease, and More), by Age Group (Adult, Pediatric and Adolescents) and by Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Global Palliative Care Market Trends and Insights

Aging Population & Rising Chronic Disease Burden

Worldwide, 48 million people are expected to die each year with serious health-related suffering by 2060, most in low- and middle-income nations . Cancer incidence among those aged >=65 is forecast to rise 70% by 2030, deepening demand for complex symptom control. Chinese studies report home-hospice patients scoring 115.7 on composite need scales, underscoring social and spiritual support gaps. In Europe, only 0.3% of older adults in Slovenia versus 30.4% in France die under palliative care, reflecting uneven capacity. Machine-learning frailty models predict palliative eligibility in elderly COPD patients with 92% accuracy, enabling earlier intervention.

Expansion of Hospice & Palliative Care Centers

Large operators are scaling; VITAS is entering 12 new US states as part of a multi-year build-out. Western Sydney's new hospital-based unit illustrates similar capacity building in Australia. In Colombia, 504 palliative-care services now provide 1.8 facilities per 100,000 residents for primary care, yet specialised coverage averages only 0.4 per 100,000, highlighting urban-rural gaps. Cameroon counts 21 mainly faith-based organisations, but limited morphine supply and policy voids inhibit reach. Accreditation reinforces quality: the Joint Commission's certification programme formalises interdisciplinary standards for inpatient units .

High Cost of Multidisciplinary Programmes in LMICs

Cost-effectiveness studies show average monthly spend for home-based palliative care of USD 1,095 in the United States, USD 1,941 in Europe and USD 2,192 across Asian programmes, figures well beyond many low-income-country budgets. Zimbabwe's need for cost-controlled home initiatives remains unmet despite compelling economic data. Latin American reviews cite accessibility, cultural perceptions and fragmented policy as persistent barriers. Training programmes for informal caregivers in Honduras were feasible but strained existing health budgets. A review of community-based models in Malawi, Uganda and Rwanda found evidence thin and funding unstable, limiting scalability.

Other drivers and restraints analyzed in the detailed report include:

1. Favourable Reimbursement & Value-Based-Care Incentives
2. Integration into Hospital Accreditation & Quality Metrics
3. Shortage of Certified Palliative Specialists

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Hospitals and clinics accounted for 45.78% of the palliative care market share in 2025 by virtue of established referral pathways and inpatient consult teams. Their programmes reduce average hospital costs, improve patient satisfaction, and operate as feeder channels to hospice services. Integration of AI-driven referral alerts is sharpening patient selection, enhancing financial returns and care quality. Home health and hospice agencies, while currently smaller, are forecast to post a 9.18% CAGR to 2031 as payment reforms shift incentives toward community settings. The palliative care market size for home-based providers benefits directly from a 2.7% uplift in the US Home Health Prospective Payment System, boosting margins for complex home visits.

Hospitals are leveraging interdisciplinary models to stabilise high-acuity patients then transition them to lower-cost venues. Leading systems have documented one avoidable admission per 1,000 resident-years in partner nursing homes after deploying dedicated palliative care teams. Home agencies are diversifying through mergers: Optum's USD 3.3 billion Amedisys deal consolidates capabilities across 522 care sites, giving the buyer scale in 37 states. Community and faith-based NGOs continue to fill gaps in low-resource regions, as evidenced by Cameroon's 21 grass-roots organisations that extend essential services where state coverage remains thin.

Routine home care controlled 55.05% of the palliative care market in 2025, underscoring patient preference for familiar surroundings. Evidence shows each home-based plan of care can avert USD 10,000 annually in heart-failure costs by reducing hospitalisations. Tele-palliative and virtual visits represent the fastest-growing niche, with a projected 9.92% CAGR, as broadband penetration and remote-monitoring tools expand. Several large payers now reimburse video-based pain-management sessions at parity with in-office consultations, accelerating adoption.

In-patient settings remain crucial for complex symptom crises, yet many hospital teams now conduct an initial bedside evaluation then pivot to video follow-ups, minimising bed days. Out-patient clinics operate structured day programmes for infusion support and caregiver respite. Digital pilots such as Convoy-Pal have proven feasible among frail, multi-morbid seniors by combining asynchronous symptom tracking with scheduled nurse touchpoints. Wearable sensors tested in oncology wards successfully relayed continuous vital signs but require refinement in data fidelity before widespread roll-out.

Complete Report Scope:

• By Provider
  • Hospitals & Clinics
  • Nursing Homes & Skilled-Nursing Facilities
  • Rehabilitation & Long-Term Care Centers
  • Home Health & Hospice Agencies
  • Community & NGO-run Centers
• By Care Setting
  • In-patient Hospital
  • Routine Home Care
  • Out-patient / Day-care Clinics
  • Tele-palliative / Virtual Care
• By Service Type
  • Pain & Symptom Management
  • Psychosocial & Spiritual Support
  • Care Coordination & Case Management
  • Bereavement & Family Support
• By Application
  • Cancer
  • Cardiovascular Diseases
  • Chronic Respiratory Diseases (COPD, etc.)
  • Dementia & Neuro-degenerative Disorders
  • Renal & Hepatic Failure
  • Other Life-limiting Conditions
• By Age Group
  • Adult
  • Pediatric & Adolescent
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America commanded 43.35% of the palliative care market in 2025, propelled by Medicare coverage, extensive hospital consult services and active private-equity investment. US policy incentives such as a 2.9% hospice payment increase and quality-measure reporting strengthen financial sustainability. Canada's provincial drug-and-transport coverage enhances cross-setting continuity, while employer-funded serious-illness benefits broaden access in commercial insurance lines. The palliative care market size for North America is further enlarged by consolidation, as large payers integrate home-health subsidiaries into coordinated networks.

Europe shows mature yet heterogeneous uptake. France records 30.4% of older adults receiving palliative services at end of life, whereas Slovenia remains at 0.3%. Germany's typology project supports national benchmarking, and the Netherlands demonstrates low hospital-death rates after robust integration of home-based palliation. The European market's steady 5.74% CAGR reflects alignment of accreditation standards, though specialist shortages in rural regions temper pace. Cross-border datasets fuel research and inform EU-level workforce planning initiatives.

Asia-Pacific is the fastest-expanding territory, expected to grow 10.98% through 2031 as demographic ageing accelerates and governments invest in hospice infrastructure. Japan refines non-cancer sedation protocols, while China pilots home-based models despite regulatory and cultural friction over family decision-making. Australia's Western Sydney build-out exemplifies regional capital spend, and the Asia Pacific Hospice Palliative Care Network coordinates training and knowledge exchange. Market penetration remains uneven, especially in South-East Asia's rural areas, but tele-health and NGO partnerships narrow some gaps.

Latin America is at an inflection point. Colombia now offers 1.8 primary palliative services per 100,000 residents yet struggles with geographic inequity; Amazonia and Orinoquia regions remain under-served. Chile projects doubling of serious-illness cases by 2050, and Brazil is rolling out national guidelines aimed at peri-urban clinics. Payment models remain largely fee-for-service, although Peru and Argentina are piloting bundled reimbursements tied to symptom-control metrics.

The Middle East and Africa face resource constraints. South Africa's hospice network is sizeable but financing relies heavily on charitable donations. Zimbabwe evaluates cost-per-suffering-day averted, but scale-up is limited by drug availability. Nigeria and Kenya experiment with community-health-worker-led approaches, supported by international NGOs. Tele-palliative care via mobile platforms shows promise in remote desert and savannah regions, though connectivity and power stability issues persist.

1. Amedisys Inc.
2. Chemed Corp. (VITAS Healthcare)
3. AccentCare Inc.
4. LHC Group
5. Genesis HealthCare
6. Honor Technology Inc. (Honor Hospice)
7. ProMedica Health System
8. Enhabit Home Health & Hospice
9. Seasons Hospice & Palliative Care
10. Kindred at Home (Humana)
11. Crossroads Hospice & Palliative Care
12. Cornerstone Hospice & Palliative Care
13. Blue Ridge Hospice
14. Hospice of the Valley
15. Cipla Palliative Care & Training Centre
16. Seymour Health
17. Lifepoint Health
18. Medio Home Health & Hospice
19. Care Hospice
20. NHPCO (industry association profile)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Aging population & rising chronic disease burden
  • 4.2.2 Expansion of hospice & palliative care centers
  • 4.2.3 Favorable reimbursement & value-based-care incentives
  • 4.2.4 Integration into hospital accreditation & quality metrics
  • 4.2.5 AI-enabled early-referral algorithms (under-reported)
  • 4.2.6 Employer-funded serious-illness benefits (under-reported)
• 4.3 Market Restraints
  • 4.3.1 High cost of multidisciplinary programs in LMICs
  • 4.3.2 Shortage of certified palliative specialists
  • 4.3.3 Opioid-stewardship regulations limiting pain protocols (under-reported)
  • 4.3.4 Cultural taboos delaying pediatric enrolment (under-reported)
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value - USD)

• 5.1 By Provider
  • 5.1.1 Hospitals & Clinics
  • 5.1.2 Nursing Homes & Skilled-Nursing Facilities
  • 5.1.3 Rehabilitation & Long-Term Care Centers
  • 5.1.4 Home Health & Hospice Agencies
  • 5.1.5 Community & NGO-run Centers
• 5.2 By Care Setting
  • 5.2.1 In-patient Hospital
  • 5.2.2 Routine Home Care
  • 5.2.3 Out-patient / Day-care Clinics
  • 5.2.4 Tele-palliative / Virtual Care
• 5.3 By Service Type
  • 5.3.1 Pain & Symptom Management
  • 5.3.2 Psychosocial & Spiritual Support
  • 5.3.3 Care Coordination & Case Management
  • 5.3.4 Bereavement & Family Support
• 5.4 By Application
  • 5.4.1 Cancer
  • 5.4.2 Cardiovascular Diseases
  • 5.4.3 Chronic Respiratory Diseases (COPD, etc.)
  • 5.4.4 Dementia & Neuro-degenerative Disorders
  • 5.4.5 Renal & Hepatic Failure
  • 5.4.6 Other Life-limiting Conditions
• 5.5 By Age Group
  • 5.5.1 Adult
  • 5.5.2 Pediatric & Adolescent
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, MarketRank/Share, Products & Services, Recent Developments)
  • 6.3.1 Amedisys Inc.
  • 6.3.2 Chemed Corp. (VITAS Healthcare)
  • 6.3.3 AccentCare Inc.
  • 6.3.4 LHC Group
  • 6.3.5 Genesis HealthCare
  • 6.3.6 Honor Technology Inc. (Honor Hospice)
  • 6.3.7 ProMedica Health System
  • 6.3.8 Enhabit Home Health & Hospice
  • 6.3.9 Seasons Hospice & Palliative Care
  • 6.3.10 Kindred at Home (Humana)
  • 6.3.11 Crossroads Hospice & Palliative Care
  • 6.3.12 Cornerstone Hospice & Palliative Care
  • 6.3.13 Blue Ridge Hospice
  • 6.3.14 Hospice of the Valley
  • 6.3.15 Cipla Palliative Care & Training Centre
  • 6.3.16 Seymour Health
  • 6.3.17 Lifepoint Health
  • 6.3.18 Medio Home Health & Hospice
  • 6.3.19 Care Hospice
  • 6.3.20 NHPCO (industry association profile)

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment